Industry News
Collision in pitch drop experiment
The University of Queensland's (UQ) pitch drop experiment marked a milestone last week as the ninth drop of pitch slowly collided with the eighth drop in the bottom of the beaker. [ + ]
Funding for prostate cancer research
Funding is available for translational research in prostate cancer. [ + ]
ResMed launches two new AirFit masks
ResMed (ASX:RMD) has added a new nasal mask and a full-face mask to its AirFit line of sleep-disordered breathing therapy devices. [ + ]
AusBiotech to submit to Senate's 'Australian innovation system' inquiry
AusBiotech is preparing a submission following the Senate's referral of an inquiry into Australia's innovation system to the Senate Economics References Committee for inquiry and report. [ + ]
The evolution of chloroquine
A different way of administering chloroquine could see its renewed use to treat malaria. [ + ]
Drawbridge anaesthetic beats propofol during trial
Drawbridge Pharmaceuticals announced that anaesthesia candidate Phaxan outperformed the SOC propofol during the first in-human trial comparing the two drugs. [ + ]
Chemical cues direct sperm in healthier choice
Cues given off by unfertilised female mussel eggs act as a genetically compatible chemoattractant to sperm. [ + ]
Queensland Government to inject $1m into MRCF
The Queensland Government will kick another $1m into the Medical Research Commercialisation Fund (MRCF), a VC fund jointly supported by the federal, Qld, Vic, NSW and WA governments. [ + ]
Nexvet raises $33.6m in financing round
Nexvet Biopharma will put the proceeds of a $33.6m Series B financing round to funding key clinical trials for its lead products, as well as expanding its development pipeline and US presence. [ + ]
TGA's low value turnover exemption scheme under review
The Therapeutic Goods Administration (TGA) has announced a review of the low value turnover exemption scheme (LVT scheme), which exempts cost recovery fees on products with low turnover. [ + ]
CSIRO bracing for cuts, claims Fairfax
Fairfax Media has published an article claiming that science body CSIRO is bracing for a May budget cut of up to $150 million, or more than 20% of its total government funding, with the organisation's top executive team modelling a range of scenarios based around this outcome. [ + ]
Innate to start recruiting for SPMS trial in June
Innate Immunotherapeutics (ASX:IIL) expects to start recruiting up to 90 secondary progressive multiple sclerosis patients for a phase IIb trial of MIS416 in June. [ + ]
ResMed gets Red Dots for respiratory products
ResMed (ASX:RMD) has secured Red Dot designation for a nasal pillow mask and a soon-to-be-launched life support ventilator at this year's awards. [ + ]
Merck Millipore announces incoming CEO and president
Merck Millipore, the life science division of Merck, has announced the appointment of Dr Udit Batra as its incoming president and CEO. Dr Batra comes to Merck Millipore from the consumer health division of Merck KGaA, where he successfully grew the business in established and emerging markets. [ + ]
Hereditary trauma demonstrated in mice
Researchers from the University of Zurich and ETH Zurich have discovered a piece in the puzzle which explains how the inheritance of traumas may be mediated. [ + ]
